Ligand validation:5VD3

H8H: N-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-7-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]-5-(TETRAHYDRO-2H-PYRAN-4-YLOXY)QUINAZOLIN-4-AMINE

H8H is a Ligand Of Interest in 5VD3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5VD3_H8H_A_401	91%	24%	0.092	0.978	0.89	2.19	2	17	0	0	100%	1
5VCX_H8H_A_401	63%	16%	0.168	0.964	1.27	2.39	3	14	0	0	100%	1
2H8H_H8H_A_534	75%	26%	0.115	0.949	0.87	2.1	1	15	2	0	100%	1
6ZGC_H8H_D_501	61%	7%	0.17	0.959	3.11	1.86	17	11	0	0	100%	1
4QMX_H8H_A_401	47%	12%	0.134	0.873	1.58	2.46	6	15	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.